Zhang YQ, et al. - A meta-analysis of published studies was conducted to determine whether or not ceftriaxone combination therapy is associated with better clinical outcomes than respiratory fluoroquinolone monotherapy for adults with community-acquired pneumonia (CAP). It was shown that ceftriaxone combination therapy was similar to respiratory fluoroquinolone monotherapy in terms of efficacy and was associated with lower drug-related adverse events.